Shana Mcclone, in Cudahy, WI - Clinical Nurse Specialist

Shana Mcclone, is a Clinical Nurse Specialist - Adult Health based in Cudahy, Wisconsin. Shana Mcclone is licensed to practice in Wisconsin (license number 5677-33) and her current practice location is 5900 S Lake Dr, Cudahy, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (414) 489-4048.

NPI number for Shana Mcclone is 1295144608 and her current mailing address is 8545 S Apple Creek Dr, Oak Creek, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1295144608.

Contact Information

	Shana Mcclone,
	5900 S Lake Dr, Cudahy, WI 53110-3171
	(414) 489-4048
	(414) 489-4153

Provider's Profile

Full Name	Shana Mcclone
Gender	Female
Speciality	Clinical Nurse Specialist - Adult Health
Location	5900 S Lake Dr, Cudahy, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1295144608
Provider Enumeration Date: 08/11/2014
Last Update Date: 08/11/2014

Medical Identifiers

Medical identifiers for Shana Mcclone such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295144608	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SA2200X	Clinical Nurse Specialist - Adult Health	5677-33 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shana Mcclone is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shana Mcclone, 8545 S Apple Creek Dr, Oak Creek, WI 53154-2633 Ph: (414) 489-4048	Shana Mcclone, 5900 S Lake Dr, Cudahy, WI 53110-3171 Ph: (414) 489-4048

News Archive

Maxygen completes joint venture transaction with Astellas Pharma

Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.

New trial plans to use text messages for identifying, reducing high blood pressure in at-risk patients

Most primary care doctors will measure a patient's blood pressure during an appointment. Emergency department physicians do, too.

Southridge provide equity capital financing for PuraMed BioScience

Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.

Novel heart monitoring device helps ER patients avoid unnecessary follow-up care

A study conducted at Scripps Health has found that a novel new heart monitoring device helped emergency room patients avoid unnecessary follow-up care. Scripps Health electrophysiologist Steven Higgins, MD, presented findings of the study titled, "Prevalence of Arrhythmias in Emergency Department Patients Discharged Using a Novel Ambulatory Cardiac Monitor", today at the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston.

Bipolar disorder genes, pathways identified

Neuroscientists at the Indiana University School of Medicine have created the first comprehensive map of genes likely to be involved in bipolar disorder, according to research published online Nov. 21 in the American Journal of Medical Genetics.

Shana Mcclone, - Clinical Nurse Specialist in Cudahy, WI